[Federal Register Volume 77, Number 16 (Wednesday, January 25, 2012)]
[Notices]
[Pages 3770-3771]
[FR Doc No: 2012-1517]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9623-3; EPA-HQ-ORD-2011-0895]

Draft Research Report: Investigation of Ground Water
Contamination near Pavillion, WY

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of extension of public comment period.

-----------------------------------------------------------------------

SUMMARY: EPA is announcing a 45-day extension to the public comment
period for the external review of the draft research report titled,
``Investigation of Ground Water Contamination near Pavillion, Wyoming''
(FRL-9506-7; 76 FR 77829). The draft research report was prepared by
the National Risk Management Research Laboratory, within the EPA Office
of Research and Development, and EPA Region 8. This draft research
report is not final as described in EPA's Information Quality
Guidelines, and does not represent and should not be construed to
represent Agency policy or views. Eastern Research Group, Inc., an EPA
contractor for external peer review, will convene an independent panel
of experts for peer review of this draft research report. Public
comments submitted during the public comment period will be made
available to the peer review panel for consideration in their review.
An external peer review meeting will take place following the public
comment period. An additional Federal Register notice will be published
about one month prior to the meeting to provide the meeting date,
location, and registration information. Additional details about the
peer review process can be found at: http://cfpub.epa.gov/si/si_public_pra_view.cfm?dirEntryID=240345.

DATES: The public comment period began December 14, 2011, and ends
March 12, 2012. Comments should be submitted to the docket or received
in writing by EPA by March 12, 2012.

ADDRESSES: The draft ``Investigation of Ground Water Contamination near
Pavillion, Wyoming.'' is available via the Internet on the EPA Region 8
site at: http://www.epa.gov/region8/superfund/wy/pavillion/EPA_ReportOnPavillion_Dec-8-2011.pdf.
    Comments may be submitted electronically via http://www.regulations.gov, by email, by mail, by facsimile, or by hand
delivery/courier. Please follow the detailed instructions provided in
the SUPPLEMENTARY INFORMATION section of this notice.
    Additional Information: For information on the docket,
www.regulations.gov, or the public comment period, please contact the
Office of Environmental Information (OEI) Docket (Mail Code: 2822T),
U.S. Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460; telephone:<PHONE_NUMBER>; facsimile: (202) 566-
1753; or email<EMAIL_ADDRESS>    For information on the draft report, please contact Rebecca Foster,
U.S. Environmental Protection Agency, P.O. Box 1198, Ada, OK 74821;
telephone:<PHONE_NUMBER>; facsimile:<PHONE_NUMBER>; or email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Information about Pavillion Ground Water Investigation

    Pavillion, Wyoming is located in Fremont County, about 20 miles
northwest of Riverton. The concern at the site is potential ground
water contamination, based on resident complaints about smells, tastes,
and adverse changes in water quality of their domestic wells. In
collaboration with ORD, Region 8 has been conducting a ground water
investigation. The purpose of this ground water investigation is to
better understand the basic ground water hydrology and how the
constituents of concern may be occurring in the aquifer. More
information is available at http://www.epa.gov/region8/superfund/wy/pavillion/.

II. How to Submit Comments to the Docket at http://www.regulations.gov

    Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2011-
0895, by one of the following methods:
     http://www.regulations.gov: Follow the on-line
instructions for submitting comments.
     Email<EMAIL_ADDRESS>     Facsimile:<PHONE_NUMBER>.
     Mail: Office of Environmental Information Docket (Mail
Code: 2822T), U.S. Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460. The telephone number is (202) 566-
1752. If you provide comments by mail, please submit one unbound
original with pages numbered consecutively, and three copies of the
comments. For attachments, provide an index, number pages consecutively
with the comments, and submit an unbound original and three copies.
     Hand Delivery: The OEI Docket is located in the EPA
Headquarters Docket Center, EPA West Building, Room 3334, 1301
Constitution Ave., NW., Washington, DC. The EPA Docket Center Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>. Deliveries are only accepted during the
docket's normal hours of operation, and special arrangements should be
made for deliveries of boxed information. If you provide comments by
hand delivery, please submit one unbound original with pages numbered
consecutively, and three copies of the comments. For attachments,
provide an index, number pages consecutively with the comments, and
submit an unbound original and three copies.
    Instructions: Direct your comments to Docket ID No. EPA-HQ-ORD-
2011-0895. Please ensure that your comments are submitted within the
specified comment period. It is EPA's policy to include all comments it
receives in the public docket without change and to make the comments
available online at http://www.regulations.gov, including any personal
information provided, unless comments include information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://www.regulations.gov or email. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means that EPA will not know
your identity or contact information unless you provide it in the body
of your comments. If you send email comments directly to EPA without
going through http://www.regulations.gov, your email address will be
automatically captured and included as part of the comments that are
placed in the public docket and made available on the Internet. If you
submit electronic comments, EPA recommends that you include your name
and other contact information in the body of your comments and with any
disk or CD-ROM you submit. If EPA cannot read your comments due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comments. Electronic files should
avoid the use of special characters and any form of encryption and be
free of any defects or viruses. For additional information about EPA's
public docket, visit the EPA Docket Center homepage at http://www.epa.gov/epahome/dockets.htm.
    Docket: All documents in the docket are listed in the http://www.regulations.gov index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, will be publicly available only in hard copy.
Publicly available docket materials are available either electronically
at http://www.regulations.gov or in hard copy at the OEI Docket in the
EPA Headquarters Docket Center.

    Dated: January 18, 2012.
Cynthia Sonich-Mullin,
Director, National Risk Management Research Laboratory.
[FR Doc. 2012-1517 Filed 1-24-12; 8:45 am]
BILLING CODE 6560-50-P


Meeting with EXP (September 20, 2006)

Participants:

Tanja Barrnet (consultant)

Gus Changaris (EXP)

Alex Myers (attorney for EXP)

Rob Ellis (EXP)

Mark Harvey (EXP)

Nadine Ewe (EXP)

Matt Hale (EPA)

Ross Elliott (EPA)

Jim Michael (EPA)

Trish Mercer (EPA)

Maria Vickers (EPA)

Meg McCarthy (EPA)

Purpose:  EXP has requested that EPA consider adding hazardous
pharmaceutical wastes to the universal waste program.   The purpose of
the meeting was to outline the issues surrounding the current management
practices of hazardous pharmaceutical wastes.

Notes:  EXP stated that the current system works well for reverse
distributors, but a problem arises when there are expired
pharmaceuticals that are not creditable.  EXP stated that few health
care facilities were aware of RCRA (very little time and resources for
RCRA).  EXP believed the allowing reverse distributors to apply their
expertise to all pharmaceutical wastes (including non-creditable
pharmaceuticals) would solve this problem.


[Federal Register Volume 86, Number 105 (Thursday, June 3, 2021)]
[Notices]
[Pages 29877-29881]
[FR Doc No: 2021-11642]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2000-7363; FMCSA-2000-7918; FMCSA-2001-9258; FMCSA-
2002-12844; FMCSA-2002-13411; FMCSA-2003-14504; FMCSA-2004-18885;
FMCSA-2006-25246; FMCSA-2007-27515; FMCSA-2007-27897; FMCSA-2008-0106;
FMCSA-2008-0266; FMCSA-2008-0292; FMCSA-2008-0340; FMCSA-2008-0398;
FMCSA-2009-0086; FMCSA-2009-0321; FMCSA-2010-0201; FMCSA-2010-0354;
FMCSA-2011-0024; FMCSA-2011-0057; FMCSA-2011-0092; FMCSA-2011-0102;
FMCSA-2012-0278; FMCSA-2012-0279; FMCSA-2012-0337; FMCSA-2012-0338;
FMCSA-2012-0339; FMCSA-2013-0024; FMCSA-2013-0027; FMCSA-2014-0004;
FMCSA-2014-0300; FMCSA-2014-0301; FMCSA-2014-0304; FMCSA-2015-0048;
FMCSA-2015-0052; FMCSA-2016-0029; FMCSA-2016-0207; FMCSA-2016-0209;
FMCSA-2016-0213; FMCSA-2016-0214; FMCSA-2016-0377; FMCSA-2017-0014;
FMCSA-2017-0017; FMCSA-2017-0018; FMCSA-2018-0006; FMCSA-2018-0013;
FMCSA-2018-0017; FMCSA-2018-0018; FMCSA-2019-0004; FMCSA-2019-0008;
FMCSA-2019-0009]

Qualification of Drivers; Exemption Applications; Vision

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).

ACTION: Notice of renewal of exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to renew exemptions for 67
individuals from the vision requirement in the Federal Motor Carrier
Safety Regulations (FMCSRs) for interstate commercial motor vehicle
(CMV) drivers. The exemptions enable these individuals to continue to
operate CMVs in interstate commerce without meeting the vision
requirements in one eye.

DATES: Each group of renewed exemptions were applicable on the dates
stated in the discussions below and will expire on the dates stated in
the discussions below. Comments must be received on or before July 6,
2021.

ADDRESSES: You may submit comments identified by the Federal Docket
Management System (FDMS) Docket No. FMCSA-2000-7363, Docket No. FMCSA-
2000-7918, Docket No. FMCSA-2001-9258, Docket No. FMCSA-2002-12844,
Docket No. FMCSA-2002-13411, Docket No. FMCSA-2003-14504, Docket No.
FMCSA-2004-18885, Docket No. FMCSA-2006-25246, Docket No. FMCSA-2007-
27515, Docket No. FMCSA-2007-27897, Docket No. FMCSA-2008-0106, Docket
No.

FMCSA-2008-0266, Docket No. FMCSA-2008-0292, Docket No. FMCSA-2008-
0340, Docket No. FMCSA-2008-0398, Docket No. FMCSA-2009-0086, Docket
No. FMCSA-2009-0321, Docket No. FMCSA-2010-0201, Docket No. FMCSA-2010-
0354, Docket No. FMCSA-2011-0024, Docket No. FMCSA-2011-0057, Docket
No. FMCSA-2011-0092, Docket No. FMCSA-2011-0102, Docket No. FMCSA-2012-
0278, Docket No. FMCSA-2012-0279, Docket No. FMCSA-2012-0337, Docket
No. FMCSA-2012-0338, Docket No. FMCSA-2012-0339, Docket No. FMCSA-2013-
0024, Docket No. FMCSA-2013-0027, Docket No. FMCSA-2014-0004, Docket
No. FMCSA-2014-0300, Docket No. FMCSA-2014-0301, Docket No. FMCSA-2014-
0304, Docket No FMCSA-2015-0048, Docket No. FMCSA-2015-0052, Docket No.
FMCSA-2016-0029, Docket No. FMCSA-2016-0207, Docket No. FMCSA-2016-
0209, Docket No. FMCSA-2016-0213, Docket No. FMCSA-2016-0214, Docket
No. FMCSA-2016-0377, Docket No. FMCSA-2017-0014, Docket No. FMCSA-2017-
0017, Docket No. FMCSA-2017-0018, Docket No. FMCSA-2018-0006, Docket
No. FMCSA-2018-0013, Docket No. FMCSA-2018-0017, Docket No. FMCSA-2018-
0018, Docket No. FMCSA-2019-0004, Docket No. FMCSA-2019-0008, or Docket
No. FMCSA-2019-0009 using any of the following methods:
     Federal eRulemaking Portal: Go to www.regulations.gov/,
insert the docket number, FMCSA-2000-7363, FMCSA-2000-7918, FMCSA-2001-
9258, FMCSA-2002-12844, FMCSA-2002-13411, FMCSA-2003-14504, FMCSA-2004-
18885, FMCSA-2006-25246, FMCSA-2007-27515, FMCSA-2007-27897, FMCSA-
2008-0106, FMCSA-2008-0266, FMCSA-2008-0292, FMCSA-2008-0340, FMCSA-
2008-0398, FMCSA-2009-0086, FMCSA-2009-0321, FMCSA-2010-0201, FMCSA-
2010-0354, FMCSA-2011-0024, FMCSA-2011-0057, FMCSA-2011-0092, FMCSA-
2011-0102, FMCSA-2012-0278, FMCSA-2012-0279, FMCSA-2012-0337, FMCSA-
2012-0338, FMCSA-2012-0339, FMCSA-2013-0024, FMCSA-2013-0027, FMCSA-
2014-0004, FMCSA-2014-0300, FMCSA-2014-0301, FMCSA-2014-0304, FMCSA-
2015-0048, FMCSA-2015-0052, FMCSA-2016-0029, FMCSA-2016-0207, FMCSA-
2016-0209, FMCSA-2016-0213, FMCSA-2016-0214, FMCSA-2016-0377, FMCSA-
2017-0014, FMCSA-2017-0017, FMCSA-2017-0018, FMCSA-2018-0006, FMCSA-
2018-0013, FMCSA-2018-0017, FMCSA-2018-0018, FMCSA-2019-0004, FMCSA-
2019-0008, or FMCSA-2019-0009 in the keyword box, and click ``Search.''
Next, sort the results by ``Posted (Newer-Older),'' choose the first
notice listed, and click on the ``Comment'' button. Follow the online
instructions for submitting comments.
     Mail: Dockets Operations; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except Federal Holidays.
     Fax:<PHONE_NUMBER>.
    To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
DOT, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through
Friday, except Federal holidays. If you have questions regarding
viewing or submitting material to the docket, contact Dockets
Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2000-7363; FMCSA-2000-7918; FMCSA-2001-9258;
FMCSA-2002-12844; FMCSA-2002-13411; FMCSA-2003-14504; FMCSA-2004-18885;
FMCSA-2006-25246; FMCSA-2007-27515; FMCSA-2007-27897; FMCSA-2008-0106;
FMCSA-2008-0266; FMCSA-2008-0292; FMCSA-2008-0340; FMCSA-2008-0398;
FMCSA-2009-0086; FMCSA-2009-0321; FMCSA-2010-0201; FMCSA-2010-0354;
FMCSA-2011-0024; FMCSA-2011-0057; FMCSA-2011-0092; FMCSA-2011-0102;
FMCSA-2012-0278; FMCSA-2012-0279; FMCSA-2012-0337; FMCSA-2012-0338;
FMCSA-2012-0339; FMCSA-2013-0024; FMCSA-2013-0027; FMCSA-2014-0004;
FMCSA-2014-0300; FMCSA-2014-0301; FMCSA-2014-0304; FMCSA-2015-0048;
FMCSA-2015-0052; FMCSA-2016-0029; FMCSA-2016-0207; FMCSA-2016-0209;
FMCSA-2016-0213; FMCSA-2016-0214; FMCSA-2016-0377; FMCSA-2017-0014;
FMCSA-2017-0017; FMCSA-2017-0018; FMCSA-2018-0006; FMCSA-2018-0013;
FMCSA-2018-0017; FMCSA-2018-0018; FMCSA-2019-0004; FMCSA-2019-0008;
FMCSA-2019-0009), indicate the specific section of this document to
which each comment applies, and provide a reason for each suggestion or
recommendation. You may submit your comments and material online or by
fax, mail, or hand delivery, but please use only one of these means.
FMCSA recommends that you include your name and a mailing address, an
email address, or a phone number in the body of your document so that
FMCSA can contact you if there are questions regarding your submission.
    To submit your comment online, go to www.regulations.gov/, insert
the docket number, FMCSA-2000-7363, FMCSA-2000-7918, FMCSA-2001-9258,
FMCSA-2002-12844, FMCSA-2002-13411, FMCSA-2003-14504, FMCSA-2004-18885,
FMCSA-2006-25246, FMCSA-2007-27515, FMCSA-2007-27897, FMCSA-2008-0106,
FMCSA-2008-0266, FMCSA-2008-0292, FMCSA-2008-0340, FMCSA-2008-0398,
FMCSA-2009-0086, FMCSA-2009-0321, FMCSA-2010-0201, FMCSA-2010-0354,
FMCSA-2011-0024, FMCSA-2011-0057, FMCSA-2011-0092, FMCSA-2011-0102,
FMCSA-2012-0278, FMCSA-2012-0279, FMCSA-2012-0337, FMCSA-2012-0338,
FMCSA-2012-0339, FMCSA-2013-0024, FMCSA-2013-0027, FMCSA-2014-0004,
FMCSA-2014-0300, FMCSA-2014-0301, FMCSA-2014-0304, FMCSA-2015-0048,
FMCSA-2015-0052, FMCSA-2016-0029, FMCSA-2016-0207, FMCSA-2016-0209,
FMCSA-2016-0213, FMCSA-2016-0214, FMCSA-2016-0377, FMCSA-2017-0014,
FMCSA-2017-0017, FMCSA-2017-0018, FMCSA-2018-0006, FMCSA-2018-0013,
FMCSA-2018-0017, FMCSA-2018-0018, FMCSA-2019-0004, FMCSA-2019-0008, or
FMCSA-2019-0009 in the keyword box, and click ``Search.'' Next, sort
the results by ``Posted (Newer-Older),'' choose the first notice
listed, click the ``Comment'' button, and type your comment into the
text box on the following screen. Choose whether you are submitting
your comment as an individual or on behalf of a third party and then
submit.

    If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. If you submit comments by mail and would
like to know that they reached the facility, please enclose a stamped,
self-addressed postcard or envelope.
    FMCSA will consider all comments and material received during the
comment period.

B. Viewing Comments

    To view comments go to www.regulations.gov, insert the docket
number, FMCSA-2000-7363, FMCSA-2000-7918, FMCSA-2001-9258, FMCSA-2002-
12844, FMCSA-2002-13411, FMCSA-2003-14504, FMCSA-2004-18885, FMCSA-
2006-25246, FMCSA-2007-27515, FMCSA-2007-27897, FMCSA-2008-0106, FMCSA-
2008-0266, FMCSA-2008-0292, FMCSA-2008-0340, FMCSA-2008-0398, FMCSA-
2009-0086, FMCSA-2009-0321, FMCSA-2010-0201, FMCSA-2010-0354, FMCSA-
2011-0024, FMCSA-2011-0057, FMCSA-2011-0092, FMCSA-2011-0102, FMCSA-
2012-0278, FMCSA-2012-0279, FMCSA-2012-0337, FMCSA-2012-0338, FMCSA-
2012-0339, FMCSA-2013-0024, FMCSA-2013-0027, FMCSA-2014-0004, FMCSA-
2014-0300, FMCSA-2014-0301, FMCSA-2014-0304, FMCSA-2015-0048, FMCSA-
2015-0052, FMCSA-2016-0029, FMCSA-2016-0207, FMCSA-2016-0209, FMCSA-
2016-0213, FMCSA-2016-0214, FMCSA-2016-0377, FMCSA-2017-0014, FMCSA-
2017-0017, FMCSA-2017-0018, FMCSA-2018-0006, FMCSA-2018-0013, FMCSA-
2018-0017, FMCSA-2018-0018, FMCSA-2019-0004, FMCSA-2019-0008, or FMCSA-
2019-0009 in the keyword box, and click ``Search.'' Next, sort the
results by ``Posted (Newer-Older),'' choose the first notice listed,
and click ``Browse Comments.'' If you do not have access to the
internet, you may view the docket online by visiting Dockets Operations
in Room W12-140 on the ground floor of the DOT West Building, 1200 New
Jersey Avenue SE, Washington, DC 20590-0001, between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except Federal holidays. To be sure someone
is there to help you, please call<PHONE_NUMBER> or<PHONE_NUMBER>
before visiting Dockets Operations.

C. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.transportation.gov/privacy.

II. Background

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statute also allows the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification.
    The physical qualification standard for drivers regarding vision
found in 49 CFR 391.41(b)(10) states that a person is physically
qualified to drive a CMV if that person has distant visual acuity of at
least 20/40 (Snellen) in each eye without corrective lenses or visual
acuity separately corrected to 20/40 (Snellen) or better with
corrective lenses, distant binocular acuity of a least 20/40 (Snellen)
in both eyes with or without corrective lenses, field of vision of at
least 70[deg] in the horizontal meridian in each eye, and the ability
to recognize the colors of traffic signals and devices showing red,
green, and amber.
    The 67 individuals listed in this notice have requested renewal of
their exemptions from the vision standard in Sec.  391.41(b)(10), in
accordance with FMCSA procedures. Accordingly, FMCSA has evaluated
these applications for renewal on their merits and decided to extend
each exemption for a renewable 2-year period.

III. Request for Comments

    Interested parties or organizations possessing information that
would otherwise show that any, or all, of these drivers are not
currently achieving the statutory level of safety should immediately
notify FMCSA. The Agency will evaluate any adverse evidence submitted
and, if safety is being compromised or if continuation of the exemption
would not be consistent with the goals and objectives of 49 U.S.C.
31136(e) and 31315(b), FMCSA will take immediate steps to revoke the
exemption of a driver.

IV. Basis for Renewing Exemptions

    In accordance with 49 U.S.C. 31136(e) and 31315(b), each of the 67
applicants has satisfied the renewal conditions for obtaining an
exemption from the vision standard (see 65 FR 45817, 65 FR 66286, 65 FR
77066, 66 FR 13825, 66 FR 17743, 66 FR 33990, 67 FR 68719, 67 FR 71610,
67 FR 76439, 68 FR 2629, 68 FR 10298, 68 FR 10300, 68 FR 19598, 68 FR
33570, 68 FR 35772, 69 FR 53493, 69 FR 62742, 69 FR 64810, 69 FR 71100,
70 FR 7545, 70 FR 7546, 70 FR 25878, 70 FR 33937, 71 FR 62148, 71 FR
66217, 72 FR 180, 72 FR 1054, 72 FR 7111, 72 FR 7812, 72 FR 9397, 72 FR
21313, 72 FR 28093, 72 FR 32703, 72 FR 32705, 72 FR 39879, 72 FR 52419,
73 FR 35194, 73 FR 51689, 73 FR 61922, 73 FR 61925, 73 FR 63047, 73 FR
63047, 73 FR 74565, 73 FR 75803, 74 FR 980, 74 FR 6209, 74 FR 6211, 74
FR 6212, 74 FR 6689, 74 FR 7097, 74 FR 15584, 74 FR 19267, 74 FR 20253,
74 FR 23472, 74 FR 26464, 74 FR 28094, 74 FR 41971, 75 FR 1835, 75 FR
9482, 75 FR 54958, 75 FR 59327, 75 FR 64396, 75 FR 64396, 75 FR 70078,
75 FR 72863, 75 FR 77949, 76 FR 2190, 76 FR 4413, 76 FR 4414, 76 FR
9859, 76 FR 9861, 76 FR 9865, 76 FR 17481, 76 FR 18824, 76 FR 21796, 76
FR 25766, 76 FR 28125, 76 FR 29022, 76 FR 29024, 76 FR 29026, 76 FR
32016, 76 FR 32017, 76 FR 34135, 76 FR 37885, 76 FR 44082, 76 FR 54530,
77 FR 10606, 77 FR 59248, 77 FR 60008, 77 FR 64582, 77 FR 64583, 77 FR
68200, 77 FR 68202, 77 FR 70534, 77 FR 71669, 77 FR 71671, 77 FR 74273,
77 FR 74731, 78 FR 798, 78 FR 1919, 78 FR 8689, 78 FR 9772, 78 FR
10250, 78 FR 11731, 78 FR 12811, 78 FR 12817, 78 FR 12822, 78 FR 16912,
78 FR 22596, 78 FR 24300, 78 FR 24798, 78 FR 29431, 78 FR 30954, 78 FR
32703, 78 FR 32708, 78 FR 34140, 78 FR 37270, 78 FR 46407, 78 FR 51268,
78 FR 78477, 79 FR 14328, 79 FR 18392, 79 FR 24298, 79 FR 29498, 79 FR
56104, 79 FR 56117, 79 FR 59357, 79 FR 65759, 79 FR 73686, 79 FR 73687,
80 FR 603, 80 FR 2473, 80 FR 3308, 80 FR 3723, 80 FR 5615, 80 FR 6162,
80 FR 7678, 80 FR 7679, 80 FR 8751, 80 FR 14223, 80 FR 15859, 80 FR
16502, 80 FR 18693, 80 FR 18696, 80 FR 20558, 80 FR 20559, 80 FR 20562,
80 FR 25766, 80 FR 25768, 80 FR 26139, 80 FR 29154, 80 FR 31635, 80 FR
31640, 80 FR 33009, 80 FR 33011, 80 FR 35699, 80 FR 36395, 80 FR 36398,
80 FR 48404, 80 FR 48409, 81 FR 20433, 81 FR 42054, 81 FR 66722, 81 FR
70248, 81 FR 70251, 81 FR 71173, 81 FR 80161, 81 FR 90046, 81 FR 96165,
81 FR 96178, 81 FR 96180, 82 FR 12678, 82 FR 13043, 82 FR 13045, 82 FR
13048, 82 FR 13187, 82 FR 15277, 82 FR 17736, 82 FR 18949, 82 FR 18956,
82 FR 20962, 82 FR 22379, 82 FR 23712, 82 FR 24430, 82 FR 26224, 82 FR
33542, 82 FR 35050, 82 FR 37499, 83 FR 6694, 83 FR 24571, 83 FR 28325,
83 FR 28335, 83 FR 34661, 83 FR 40648, 83 FR 45750, 83 FR 53724, 83 FR
53727, 83 FR 56137, 83 FR 56902, 84 FR 2311, 84 FR

2314, 84 FR 2326, 84 FR 2328, 84 FR 5550, 84 FR 12665, 84 FR 16320, 84
FR 16327, 84 FR 16333, 84 FR 21397, 84 FR 21401, 84 FR 23629, 84 FR
27688, 84 FR 47047, 84 FR 47057). They have submitted evidence showing
that the vision in the better eye continues to meet the requirement
specified at Sec.  391.41(b)(10) and that the vision impairment is
stable. In addition, a review of each record of safety while driving
with the respective vision deficiencies over the past 2 years indicates
each applicant continues to meet the vision exemption requirements.
These factors provide an adequate basis for predicting each driver's
ability to continue to drive safely in interstate commerce. Therefore,
FMCSA concludes that extending the exemption for each renewal applicant
for a period of 2 years is likely to achieve a level of safety equal to
that existing without the exemption.
    In accordance with 49 U.S.C. 31136(e) and 31315(b), the following
groups of drivers received renewed exemptions in the month of July and
are discussed below. As of July 22, 2021, and in accordance with 49
U.S.C. 31136(e) and 31315(b), the following 65 individuals have
satisfied the renewal conditions for obtaining an exemption from the
vision requirement in the FMCSRs for interstate CMV drivers (65 FR
45817, 65 FR 66286, 65 FR 77066, 66 FR 13825, 66 FR 17743, 66 FR 33990,
67 FR 68719, 67 FR 71610, 67 FR 76439, 68 FR 2629, 68 FR 10298, 68 FR
10300, 68 FR 19598, 68 FR 33570, 68 FR 35772, 69 FR 53493, 69 FR 62742,
69 FR 64810, 69 FR 71100, 70 FR 7545, 70 FR 7546, 70 FR 25878, 70 FR
33937, 71 FR 62148, 71 FR 66217, 72 FR 180, 72 FR 1054, 72 FR 7111, 72
FR 7812, 72 FR 9397, 72 FR 21313, 72 FR 28093, 72 FR 32703, 72 FR
32705, 72 FR 39879, 72 FR 52419, 73 FR 35194, 73 FR 51689, 73 FR 61922,
73 FR 61925, 73 FR 63047, 73 FR 63047, 73 FR 74565, 73 FR 75803, 74 FR
980, 74 FR 6209, 74 FR 6211, 74 FR 6212, 74 FR 6689, 74 FR 7097, 74 FR
15584, 74 FR 19267, 74 FR 20253, 74 FR 23472, 74 FR 26464, 74 FR 28094,
74 FR 41971, 75 FR 1835, 75 FR 9482, 75 FR 54958, 75 FR 59327, 75 FR
64396, 75 FR 64396, 75 FR 70078, 75 FR 72863, 75 FR 77949, 76 FR 2190,
76 FR 4413, 76 FR 4414, 76 FR 9859, 76 FR 9861, 76 FR 9865, 76 FR
17481, 76 FR 18824, 76 FR 21796, 76 FR 25766, 76 FR 28125, 76 FR 29022,
76 FR 29024, 76 FR 29026, 76 FR 32016, 76 FR 32017, 76 FR 34135, 76 FR
37885, 76 FR 44082, 76 FR 54530, 77 FR 10606, 77 FR 59248, 77 FR 60008,
77 FR 64582, 77 FR 64583, 77 FR 68200, 77 FR 68202, 77 FR 70534, 77 FR
71669, 77 FR 71671, 77 FR 74273, 77 FR 74731, 78 FR 798, 78 FR 1919, 78
FR 8689, 78 FR 9772, 78 FR 10250, 78 FR 11731, 78 FR 12811, 78 FR
12817, 78 FR 12822, 78 FR 16912, 78 FR 22596, 78 FR 24300, 78 FR 29431,
78 FR 30954, 78 FR 32703, 78 FR 32708, 78 FR 34140, 78 FR 37270, 78 FR
51268, 78 FR 78477, 79 FR 14328, 79 FR 18392, 79 FR 24298, 79 FR 29498,
79 FR 56104, 79 FR 56117, 79 FR 59357, 79 FR 65759, 79 FR 73686, 79 FR
73687, 80 FR 603, 80 FR 2473, 80 FR 3308, 80 FR 3723, 80 FR 6162, 80 FR
767, 80 FR 5615, 80 FR 7679, 80 FR 8751, 80 FR 14223, 80 FR 15859, 80
FR 16502, 80 FR 18693, 80 FR 18696, 80 FR 20558, 80 FR 20559, 80 FR
20562, 80 FR 25766, 80 FR 25768, 80 FR 26139, 80 FR 29154, 80 FR 31635,
80 FR 31640, 80 FR 33009, 80 FR 33011, 80 FR 36398, 80 FR 48409, 81 FR
20433, 81 FR 42054, 81 FR 66722, 81 FR 70248, 81 FR 70251, 81 FR 71173,
81 FR 80161, 81 FR 90046, 81 FR 96165, 81 FR 96178, 81 FR 96180, 82 FR
12678, 82 FR 13043, 82 FR 13045, 82 FR 13048, 82 FR 13187, 82 FR 15277,
82 FR 17736, 82 FR 18949, 82 FR 18956, 82 FR 20962, 82 FR 22379, 82 FR
23712, 82 FR 24430, 82 FR 26224, 82 FR 33542, 82 FR 35050, 82 FR 37499,
83 FR 6694, 83 FR 24571, 83 FR 28325, 83 FR 28335, 83 FR 34661, 83 FR
40648, 83 FR 45750, 83 FR 53724, 83 FR 53727, 83 FR 56137, 83 FR 56902,
84 FR 2311, 84 FR 2314, 84 FR 2326, 84 FR 2328, 84 FR 5550, 84 FR
12665, 84 FR 16320, 84 FR 16327, 84 FR 16333, 84 FR 21397, 84 FR 21401,
84 FR 23629, 84 FR 27688, 84 FR 47047, 84 FR 47057):

Charles H. Akers, Jr. (VA)
Sava A. Andjelich (IN)
Thomas J. Boss (IL)
Daniel M. Cannon (OR)
Toby L. Carson (TN)
John P. Catalano (NJ)
Jose S. Chavez (AZ)
Brett L. Condon (MD)
Stephen L. Cornish (MN)
Michael S. Crawford (IL)
Jose G. Cruz Romero (TX)
Stephen M. Currie (TX)
Dudley G. Diebold (CT)
Wayne L. Dorbert (PA)
Irvin L. Eaddy (SC)
Douglas Eamens (NY)
Matthew T. Eggers (IA)
Marc Enderson (ND)
Kelly L. Ewing (PA)
Breck L. Falcon (LA)
Jevont D. Fells (AL)
Raymundo Flores (TX)
Jeremy L. Fricke (ND)
James P. Gapinski (MN)
Dolan A. Gonzalez, Jr. (FL)
Peter D. Gouge (IA)
Michael D. Greene (VT)
Donald L. Hamrick (KS)
Zane G. Harvey, Jr. (VA)
Billy R. Holdman (IL)
James S. Hummel (PA)
Ronald D. Jackman II (NV)
Alan L. Johnston (IL)
Damian Klyza (NJ)
Alfred R. Knotts (PA)
Kevin R. Lambert (NC)
James W. Lappan (KS)
Thomas M. Leonard (PA)
Terry L. Lipscomb (AL)
Collin C. Longacre (PA)
Kenny Y. Louie (CA)
Phillip L. Mangen (OH)
Kenton D. McCullough (VA)
Anthony R. Melton (SC)
Joshua G. Millican (OH)
Stuart W. Penner (KS)
Patrick A. Piekkola (WY)
Daniel A. Rau (NJ)
Donald G. Reed (FL)
Richard S. Rehbein (MN)
Menno H. Reiff (PA)
Jeffrey Ridenhour (AR)
Patrick W. Shea (MA)
Ranjodh Singh (CA)
Jeremichael Steele (NC)
Dustin N. Sullivan (MD)
Randall S. Surber (WV)
Thomas R. Test (VA)
Francisco J. Torres (PA)
Kevin W. Van Arsdol (CO)
Christopher A. Weidner (CT)
Gerald L. Wheeler (FL)
Don S. Williams (AL)
Michael T. Wimber (MT)
Rick L. Wood (PA)

    The drivers were included in docket numbers FMCSA-2000-7363, FMCSA-
2000-7918, FMCSA-2001-9258, FMCSA-2002-12844, FMCSA-2002-13411, FMCSA-
2003-14504, FMCSA-2004-18885, FMCSA-2006-25246, FMCSA-2007-27515,
FMCSA-2007-27897, FMCSA-2008-0106, FMCSA-2008-0266, FMCSA-2008-0292,
FMCSA-2008-0340, FMCSA-2008-0398, FMCSA-2009-0086, FMCSA-2009-0321,
FMCSA-2010-0201, FMCSA-2010-0354, FMCSA-2011-0024, FMCSA-2011-0057,
FMCSA-2011-0092, FMCSA-2011-0102, FMCSA-2012-0278, FMCSA-2012-0279,
FMCSA-2012-0337, FMCSA-2012-0338, FMCSA-2012-0339, FMCSA-2013-0024,
FMCSA-2014-0004, FMCSA-2014-0300, FMCSA-2014-0301, FMCSA-2014-0304,
FMCSA-2015-0048, FMCSA-2016-0029, FMCSA-2016-0207, FMCSA-2016-0209,
FMCSA-2016-0213, FMCSA-2016-0214, FMCSA-2016-0377, FMCSA-2017-0014,
FMCSA-2017-0017, FMCSA-2017-0018, FMCSA-2018-0006, FMCSA-2018-0013,
FMCSA-2018-0017, FMCSA-2018-0018, FMCSA-2019-0004, FMCSA-2019-0008, and
FMCSA-2019-0009. Their exemptions are applicable as of July 22, 2021,
and will expire on July 22, 2023.

    As of July 23, 2021, and in accordance with 49 U.S.C. 31136(e) and
31315(b), the following individual has satisfied the renewal conditions
for obtaining an exemption from the vision requirement in the FMCSRs
for interstate CMV drivers (80 FR 35699, 80 FR 48404, 82 FR 33542, 84
FR 47057):

Bradley J. Kearl (UT)

    The driver was included in docket number FMCSA-2015-0052. The
exemption is applicable as of July 23, 2021, and will expire on July
23, 2023.
    As of July 31, 2021, and in accordance with 49 U.S.C. 31136(e) and
31315(b), the following individual has satisfied the renewal conditions
for obtaining an exemption from the vision requirement in the FMCSRs
for interstate CMV drivers (78 FR 24798, 78 FR 46407, 80 FR 36395, 82
FR 33542, 84 FR 47057):

Edward Swaggerty, Jr. (OH)

    The driver was included in docket number FMCSA-2013-0027. The
exemption is applicable as of July 31, 2021, and will expire on July
31, 2023.

V. Conditions and Requirements

    The exemptions are extended subject to the following conditions:
(1) Each driver must undergo an annual physical examination (a) by an
ophthalmologist or optometrist who attests that the vision in the
better eye continues to meet the requirements in 49 CFR 391.41(b)(10),
and (b) by a certified medical examiner (ME), as defined by Sec.
390.5, who attests that the driver is otherwise physically qualified
under Sec.  391.41; (2) each driver must provide a copy of the
ophthalmologist's or optometrist's report to the ME at the time of the
annual medical examination; and (3) each driver must provide a copy of
the annual medical certification to the employer for retention in the
driver's qualification file or keep a copy of his/her driver's
qualification if he/her is self-employed. The driver must also have a
copy of the exemption when driving, for presentation to a duly
authorized Federal, State, or local enforcement official. The exemption
will be rescinded if: (1) The person fails to comply with the terms and
conditions of the exemption; (2) the exemption has resulted in a lower
level of safety than was maintained before it was granted; or (3)
continuation of the exemption would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and 31315(b).

VI. Preemption

    During the period the exemption is in effect, no State shall
enforce any law or regulation that conflicts with this exemption with
respect to a person operating under the exemption.

VI. Conclusion

    Based upon its evaluation of the 67 exemption applications, FMCSA
renews the exemptions of the aforementioned drivers from the vision
requirement in Sec.  391.41(b)(10), subject to the requirements cited
above. In accordance with 49 U.S.C. 31136(e) and 31315(b), each
exemption will be valid for two years unless revoked earlier by FMCSA.

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2021-11642 Filed 6-2-21; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register: March 15, 2010 (Volume 75, Number 49)]
[Proposed Rules]
[Page 12158-12161]
[DOCID:fr15mr10-12]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2010-0222; Directorate Identifier 2008-NM-012-AD]
RIN 2120-AA64

Airworthiness Directives; BAE SYSTEMS (Operations) Limited Model
Avro 146-RJ and BAe 146 Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to adopt a new airworthiness directive (AD) for the
products listed above. This proposed AD results from mandatory
continuing airworthiness information (MCAI) originated by an aviation
authority of another country to identify and correct an unsafe
condition on an aviation product. The MCAI describes the unsafe
condition as:

    A potential fleet wide problem has been identified regarding the
interchanging of wing links on all BAe 146 & AVRO 146-RJ aircraft
during scheduled maintenance. Some

operators erroneously believed that these parts were
interchangeable. The effects of changing winglinks has resulted in
either a shorter or longer wing link being fitted, which introduces
local stresses in the wing top and bottom surfaces local to rib 2,
wing links and wing link fitting attachment and the fuselage local
to Frames 26 and 29. This condition, if not corrected, could result
in a reduction of structural integrity of the fuselage/wing
attachment with possible catastrophic consequences.

    The unsafe condition could result in loss of a wing or
controllability of the airplane. The proposed AD would require actions
that are intended to address the unsafe condition described in the
MCAI.

DATES: We must receive comments on this proposed AD by April 29, 2010.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://
www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-40, 1200 New
Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    For service information identified in this proposed AD, contact BAE
Systems Regional Aircraft, 13850 McLearen Road, Herndon, Virginia
20171; telephone<PHONE_NUMBER>; e-mail<EMAIL_ADDRESS>
Internet http://www.baesystems.com/Businesses/RegionalAircraft/
index.htm. You may review copies of the referenced service information
at the FAA, Transport Airplane Directorate, 1601 Lind Avenue, SW.,
Renton, Washington. For information on the availability of this
material at the FAA, call<PHONE_NUMBER> or<PHONE_NUMBER>.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://
www.regulations.gov; or in person at the Docket Operations office
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this proposed AD, the regulatory
evaluation, any comments received, and other information. The street
address for the Docket Operations office (telephone<PHONE_NUMBER>) is
in the ADDRESSES section. Comments will be available in the AD docket
shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Todd Thompson, Aerospace Engineer,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
1601 Lind Avenue, SW., Renton, Washington 98057-3356; telephone (425)
227-1175; fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2010-0222;
Directorate Identifier 2008-NM-012-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD based on those comments.
    We have lengthened the 30-day comment period for proposed ADs that
address MCAI originated by aviation authorities of other countries to
provide adequate time for interested parties to submit comments. The
comment period for these proposed ADs is now typically 45 days, which
is consistent with the comment period for domestic transport ADs.
    We will post all comments we receive, without change, to http://
www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Community, has issued EASA
Airworthiness Directive 2008-0003, dated January 8, 2008 (referred to
after this as ``the MCAI''), to correct an unsafe condition for the
specified products. The MCAI states:

    A potential fleet wide problem has been identified regarding the
interchanging of wing links on all BAe 146 & AVRO 146-RJ aircraft
during scheduled maintenance. Some operators erroneously believed
that these parts were interchangeable. The effects of changing
winglinks has resulted in either a shorter or longer wing link being
fitted, which introduces local stresses in the wing top and bottom
surfaces local to rib 2, wing links and wing link fitting attachment
and the fuselage local to Frames 26 and 29. This condition, if not
corrected, could result in a reduction of structural integrity of
the fuselage/wing attachment with possible catastrophic
consequences.
    For the reasons described above, the present Airworthiness
Directive (AD) requires the accomplishment of inspections and
rectification actions, as necessary.

    The unsafe condition could result in loss of a wing or
controllability of the airplane. The inspections include inspecting
wing links for incorrect part numbers (i.e., parts that are not
original), inspecting to determine wing geometry measurements, and
inspecting the wing link, bores, bolts, and nuts for corrosion.
Corrective actions include installing wing-to-fuselage fairings and
repairing. You may obtain further information by examining the MCAI in
the AD docket.

Relevant Service Information

    BAE Systems (Operations) Limited has issued Inspection Service
Bulletin ISB.53-175, Revision 1, dated April 2, 2007. The actions
described in this service information are intended to correct the
unsafe condition identified in the MCAI.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to our bilateral agreement with the State of Design Authority, we have
been notified of the unsafe condition described in the MCAI and service
information referenced above. We are proposing this AD because we
evaluated all pertinent information and determined an unsafe condition
exists and is likely to exist or develop on other products of the same
type design.

Differences Between This AD and the MCAI or Service Information

    We have reviewed the MCAI and related service information and, in
general, agree with their substance. But we might have found it
necessary to use different words from those in the MCAI to ensure the
AD is clear for U.S. operators and is enforceable. In making these
changes, we do not intend to differ substantively from the information
provided in the MCAI and related service information.
    We might also have proposed different actions in this AD from those
in the MCAI in order to follow FAA policies. Any such differences are
highlighted in a NOTE within the proposed AD.

Costs of Compliance

    Based on the service information, we estimate that this proposed AD
would affect about 1 product of U.S. registry. We also estimate that it
would take about 180 work-hours per product to comply with the basic
requirements of

this proposed AD. The average labor rate is $85 per work-hour. Required
parts would cost about $0 per product. Where the service information
lists required parts costs that are covered under warranty, we have
assumed that there will be no charge for these costs. As we do not
control warranty coverage for affected parties, some parties may incur
costs higher than estimated here. Based on these figures, we estimate
the cost of the proposed AD on the U.S. operator to be $15,300.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979); and
    3. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this proposed AD and placed it in the AD docket.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

    1. The authority citation for part 39 continues to read as follows:

    Authority: 49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

    2. The FAA amends Sec.  39.13 by adding the following new AD:

BAE SYSTEMS (Operations) Limited: Docket No. FAA-2010-0222;
Directorate Identifier 2008-NM-012-AD.

Comments Due Date

    (a) We must receive comments by April 29, 2010.

Affected ADs

    (b) None.

Applicability

    (c) This AD applies to BAE Systems (Operations) Limited Model
BAe 146-100A, -200A, and -300A; and Avro 146-RJ70A, 146-RJ85A, and
146-RJ100A airplanes; all serial numbers; certificated in any
category; as identified in paragraph 1.A.(1) of BAE (Operations)
Limited Inspection Service Bulletin ISB.53-175, Revision 1, dated
April 2, 2007.

Subject

    (d) Air Transport Association (ATA) of America Code 57: Wings.

Reason

    (e) The mandatory continuing airworthiness information (MCAI)
states:

    ``A potential fleet wide problem has been identified regarding
the interchanging of wing links on all BAe 146 & AVRO 146-RJ
aircraft during scheduled maintenance. Some operators erroneously
believed that these parts were interchangeable. The effects of
changing winglinks has resulted in either a shorter or longer wing
link being fitted, which introduces local stresses in the wing top
and bottom surfaces local to rib 2, wing links and wing link fitting
attachment and the fuselage local to Frames 26 and 29. This
condition, if not corrected, could result in a reduction of
structural integrity of the fuselage/wing attachment with possible
catastrophic consequences.
    ``For the reasons described above, the present Airworthiness
Directive (AD) requires the accomplishment of inspections and
rectification actions, as necessary.''

    The unsafe condition could result in loss of a wing or
controllability of the airplane. The inspections include inspecting
wing links for incorrect part numbers (i.e., parts that are not
original), inspecting to determine wing geometry measurements, and
inspecting the wing link, bores, bolts, and nuts for corrosion.
Corrective actions include installing wing-to-fuselage fairings and
repairing.

Compliance

    (f) You are responsible for having the actions required by this
AD performed within the compliance times specified, unless the
actions have already been done.

Actions

    (g) Do the following actions.
    (1) For airplanes subject to Maintenance Review Board Report
(MRBR) requirements: Within 30 days after the effective date of this
AD, revise the supplemental structural inspection (SSI) portion of
the airplane inspection schedule, in accordance with paragraph
1.D.(2) of BAE SYSTEMS (Operations) Limited Inspection Service
Bulletin ISB.53-175, Revision 1, dated April 2, 2007. Do the initial
inspection at the applicable time, and repeat at the applicable
intervals, as specified in Appendix 3 of BAE SYSTEMS (Operations)
Limited Inspection Service Bulletin ISB.53-175, Revision 1, dated
April 2, 2007. Where Appendix 3 of BAE SYSTEMS (Operations) Limited
Inspection Service Bulletin ISB.53-175, Revision 1, dated April 2,
2007, does not specify a compliance time in either flight cycles or
in flight hours, use flight cycles.
    (2) For airplanes subject to MRBR requirements: Accomplishing
the inspections and all applicable corrective actions of paragraph
1.D.(3) of BAE SYSTEMS (Operations) Limited Inspection Service
Bulletin ISB.53-175, Revision 1, dated April 2, 2007, terminates the
revisions to the SSI portion of the airplane inspection schedule
incorporated in accordance with paragraph (g)(1) of this AD,
provided that if any corrosion is found during any inspection
specified in ``Part C'' or ``Part D'' of paragraph 2.C. of BAE
SYSTEMS (Operations) Limited Inspection Service Bulletin ISB.53-175,
Revision 1, dated April 2, 2007, repair is accomplished before
further flight using a method approved by the Manager, International
Branch, ANM 116, Transport Airplane Directorate, FAA, or EASA (or
its delegated agent).
    (3) For operational airplanes subject to MRBR-to-Supplemental-
Structural-Inspection-Document (SSID) transition requirements or to
SSID requirements: Within 5,000 flight cycles after the effective
date of this AD, do the inspections and all applicable corrective
actions, in accordance with paragraph 2.C. of the Accomplishment
Instructions of BAE SYSTEMS (Operations) Limited Inspection Service
Bulletin ISB.53-175, Revision 1, dated April 2, 2007, except if any
corrosion is found during any inspection specified in ``Part C'' or
``Part D'' of paragraph 2.C. of BAE SYSTEMS (Operations) Limited
Inspection Service Bulletin ISB.53-175, Revision 1, dated April 2,
2007, repair must be accomplished using a method approved by the
Manager, International Branch, ANM 116, Transport Airplane
Directorate, FAA, or EASA (or its delegated agent). Do all
applicable corrective

actions before further flight, except that replacements of all the
wing links that are not within the specified tolerance must be done
before the airplane reaches its MRBR airframe life limit.

    Note 1: For the purposes of this AD, a detailed inspection is:
``An intensive examination of a specific item, installation, or
assembly to detect damage, failure, or irregularity. Available
lighting is normally supplemented with a direct source of good
lighting at an intensity deemed appropriate. Inspection aids such as
mirror, magnifying lenses, etc., may be necessary. Surface cleaning
and elaborate procedures may be required.''

    (4) For any inspection done in accordance with paragraph (g)(2)
or (g)(3) of this AD: Send reports to BAE SYSTEMS, Customer Liaison,
Customer Support (Building 37), BAE SYSTEMS (Operations) Limited,
Prestwick International Airport, Ayrshire, KA9 2RW, Scotland, Fax
+44 (0) 1292 675432, e-mail<EMAIL_ADDRESS>at the
applicable time in paragraph (g)(4)(i) or (g)(4)(ii) of this AD. The
report must include the inspection results, a description of any
discrepancies found, the airplane serial number, and the number of
landings and flight hours on the airplane.
    (i) If the inspection was done on or after the effective date of
this AD: Submit the report within 30 days after the inspection.
    (ii) If the inspection was done before the effective date of
this AD: Submit the report within 30 days after the effective date
of this AD.
    (5) For airplanes that are non-operational as of the effective
date of this AD and that are subject to MRBR-to-SSID transition
requirements or to SSID requirements: Before returning any airplane
to service, do the inspections and all applicable corrective
actions, in accordance with paragraph 2.C. of the Accomplishment
Instructions of BAE SYSTEMS (Operations) Limited Inspection Service
Bulletin ISB.53-175, Revision 1, dated April 2, 2007, except if any
corrosion is found during any inspection specified in ``Part C'' or
``Part D'' of paragraph 2.C. of BAE SYSTEMS (Operations) Limited
Inspection Service Bulletin ISB.53-175, Revision 1, dated April 2,
2007, repair must be accomplished using a method approved by the
Manager, International Branch, ANM 116, Transport Airplane
Directorate, FAA, or EASA (or its delegated agent).
    (6) Actions accomplished before the effective date of this AD in
accordance with BAE SYSTEMS (Operations) Limited Inspection Service
Bulletin ISB.53-175, dated December 21, 2006, are considered
acceptable for compliance with the corresponding action specified in
this AD.

FAA AD Differences

    Note 2: This AD differs from the MCAI and/or service information
as follows: The MCAI does not specify a corrective action if
corrosion is found during accomplishment of the actions specified in
``Part C'' and ``Part D'' of paragraph 2.C. of BAE SYSTEMS
(Operations) Limited Inspection Service Bulletin ISB.53-175,
Revision 1, dated April 2, 2007. This AD requires that if any
corrosion is found, a repair must be done in accordance with a
method approved by the FAA or EASA (or its delegated agent).

Other FAA AD Provisions

    (h) The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Branch, ANM-116, FAA, has the authority to approve
AMOCs for this AD, if requested using the procedures found in 14 CFR
39.19. Send information to ATTN: Todd Thompson, Aerospace Engineer,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
1601 Lind Avenue, SW., Renton, Washington 98057-3356; telephone
(425) 227-1175; fax<PHONE_NUMBER>. Before using any approved AMOC
on any airplane to which the AMOC applies, notify your principal
maintenance inspector (PMI) or principal avionics inspector (PAI),
as appropriate, or lacking a principal inspector, your local Flight
Standards District Office. The AMOC approval letter must
specifically reference this AD.
    (2) Airworthy Product: For any requirement in this AD to obtain
corrective actions from a manufacturer or other source, use these
actions if they are FAA-approved. Corrective actions are considered
FAA-approved if they are approved by the State of Design Authority
(or their delegated agent). You are required to assure the product
is airworthy before it is returned to service.
    (3) Reporting Requirements: For any reporting requirement in
this AD, under the provisions of the Paperwork Reduction Act (44
U.S.C. 3501 et seq.), the Office of Management and Budget (OMB) has
approved the information collection requirements and has assigned
OMB Control Number 2120-0056.

Related Information

    (i) Refer to MCAI EASA Airworthiness Directive 2008-0003, dated
January 8, 2008; and BAE SYSTEMS (Operations) Limited Inspection
Service Bulletin ISB.53-175, Revision 1, dated April 2, 2007; for
related information.

    Issued in Renton, Washington on March 4, 2010.
Suzanne Masterson,
Acting Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2010-5513 Filed 3-12-10; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 87, Number 33 (Thursday, February 17, 2022)]
[Notices]
[Page 9057]
[FR Doc No: 2022-03420]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-0895]

Issuance of Priority Review Voucher; Material Threat Medical
Countermeasure Product

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
issuance of a priority review voucher to the sponsor of a material
threat medical countermeasure (MCM) product application. The Federal
Food, Drug, and Cosmetic Act (FD&C Act), as amended by the 21st Century
Cures Act (Cures Act), authorizes FDA to award priority review vouchers
to sponsors of approved material threat MCM product applications that
meet certain criteria. FDA is required to publish notice of the award
of the priority review voucher. FDA has determined that SPIKEVAX
(COVID-19 Vaccine, mRNA), meets the criteria for a material threat
priority review voucher, which has been issued to ModernaTX, Inc., the
holder of the biologics license application.

FOR FURTHER INFORMATION CONTACT: Myrna Hanna, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION: FDA is announcing the issuance of a material
threat MCM priority review voucher to the sponsor of an approved
material threat MCM product application. Under section 565A of the FD&C
Act (21 U.S.C. 360bbb-4a), which was added by the Cures Act (Pub. L.
114-255), FDA will award priority review vouchers to sponsors of
approved material threat MCM product applications that meet certain
criteria upon approval of those applications. FDA has determined that
SPIKEVAX (COVID-19 Vaccine, mRNA), meets the criteria for a material
threat MCM priority review voucher. SPIKEVAX is indicated for active
immunization to prevent coronavirus disease 2019 (COVID-19) caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
individuals 18 years of age and older.
    For further information about the material threat MCM Priority
Review Voucher Program and for a link to the full text of section 565A
of the FD&C Act, go to https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/mcm-related-counterterrorism-legislation. For further information about SPIKEVAX,
(COVID-19 Vaccine, mRNA), go to the Center for Biologics Evaluation and
Research Approved Vaccine Products website at https://www.fda.gov/vaccines-blood-biologics/vaccines/approved-vaccine-products.

    Dated: February 11, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-03420 Filed 2-16-22; 8:45 am]
BILLING CODE 4164-01-P